Cyamémazine

The cyamémazine is a Médicament Antipsychotique. It is a sedative Neuroleptique especially used for its powerful anxiolytic action, marketed in France since 1972.

Chemical class

It is a derivative of the Phénothiazine.

Pharmacological properties

  • Psycholeptique
  • Nerve sedative

Mechanism of action

Complex, the action of many neuro-transmitters at the cerebral level blocks.

Indications

  • acute or chronic psychoses;

  • maniaco-depressive psychoses;
  • schizophrenia;
  • state of aggressiveness;
  • severe depression.

Side effects

  • malignant Syndrome of the nerve sedatives engaging the vital prognosis;

  • spasms;
  • instability of the face and the neck;
  • tremors;
  • turbid of accommodation;
  • retention of urine;
  • constipation;
  • turbid of the rules;
  • impotence;
  • hypertrophy of the centres;
  • lacteous secretion;
  • taken weight;
  • photosensitization;
  • cutaneous allergy.

Precautions for use

Certain undesirable effects of Cyamémazine are serious (at the vital risk) and must justify the immediate ringing of medical emergency (SAMU: 15; Firemen: 18): it is about the malignant syndrome of nerve sedatives appearing by a muscular stiffness, fever, disorders of mood, an excessive perspiration, an arrhythmia and variations of the blood pressure.

Counter-indications

Absolute:

  • allergy to the phénothiazines
  • Parkinson's disease.

Relative:

  • epilepsy;
  • cardiac failure;
  • serious impaired renal function;
  • hepatic insufficiency engraves…

Specialities

External bond

Random links:Fender Rhodos | Chargey-the-Gray | Eublepharinae | GB Railfreight | Penelope (group) | Saint-Martin-DES-Entrées